126 related articles for article (PubMed ID: 37495969)
1. Role of pelitinib in the regulation of migration and invasion of hepatocellular carcinoma cells via inhibition of Twist1.
Lee S; Kang E; Lee U; Cho S
BMC Cancer; 2023 Jul; 23(1):703. PubMed ID: 37495969
[TBL] [Abstract][Full Text] [Related]
2. Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways.
Song J; Guan Z; Song C; Li M; Gao Z; Zhao Y
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846786
[TBL] [Abstract][Full Text] [Related]
3. Degradation of FAK-targeting by proteolytic targeting chimera technology to inhibit the metastasis of hepatocellular carcinoma.
Zhang X; Li S; Song M; Chen Y; Chang L; Liu Z; Dai H; Wang Y; Yang G; Jiang Y; Lu Y
Oncol Res; 2024; 32(4):679-690. PubMed ID: 38560575
[TBL] [Abstract][Full Text] [Related]
4. Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
Li X; Su H; Tang W; Shu S; Zhao L; Sun J; Fan H
Invest New Drugs; 2024 Apr; 42(2):185-195. PubMed ID: 38372948
[TBL] [Abstract][Full Text] [Related]
5. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
[TBL] [Abstract][Full Text] [Related]
7. Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells.
Wang Z; Yang J; Fisher T; Xiao H; Jiang Y; Yang C
Environ Health Perspect; 2012 Jan; 120(1):92-7. PubMed ID: 21954225
[TBL] [Abstract][Full Text] [Related]
8. Harmine inhibits breast cancer cell migration and invasion by inducing the degradation of Twist1.
Nafie E; Lolarga J; Lam B; Guo J; Abdollahzadeh E; Rodriguez S; Glackin C; Liu J
PLoS One; 2021; 16(2):e0247652. PubMed ID: 33626096
[TBL] [Abstract][Full Text] [Related]
9. Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation.
Steinway SN; Zañudo JG; Ding W; Rountree CB; Feith DJ; Loughran TP; Albert R
Cancer Res; 2014 Nov; 74(21):5963-77. PubMed ID: 25189528
[TBL] [Abstract][Full Text] [Related]
10. All Three AKT Isoforms Can Upregulate Oxygen Metabolism and Lactate Production in Human Hepatocellular Carcinoma Cell Lines.
Tian LY; Smit DJ; Popova NV; Horn S; Velasquez LN; Huber S; Jücker M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396845
[TBL] [Abstract][Full Text] [Related]
11. GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway.
Wang Y; Fang X; Xie H; Wang X
Biochem Genet; 2024 May; ():. PubMed ID: 38789846
[TBL] [Abstract][Full Text] [Related]
12. Psilostachyin C reduces malignant properties of hepatocellular carcinoma cells by blocking CREBBP-mediated transcription of GATAD2B.
Jiang K; Ning N; Huang J; Chang Y; Wang R; Ma J
Funct Integr Genomics; 2024 Apr; 24(2):75. PubMed ID: 38600341
[TBL] [Abstract][Full Text] [Related]
13. CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway.
Zheng SS; Wu JF; Wu WX; Hu JW; Zhang D; Huang C; Zhang BH
Hepatol Int; 2024 May; ():. PubMed ID: 38769286
[TBL] [Abstract][Full Text] [Related]
14. Okadaic acid promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting protein phosphatase 2A.
Kong J; Li D; Zhang S; Zhang H; Fu Y; Qian B; Bei C; Tan S; Zhu X
J Cell Biochem; 2020 Jan; ():. PubMed ID: 31904141
[TBL] [Abstract][Full Text] [Related]
15.
Liu Z; Sun Z; Zhang D; Ma C; Jiang Y; Cao G; Sun C; Li K; Xu D; Liu J; Zhao S
Transl Cancer Res; 2020 Oct; 9(10):5994-6004. PubMed ID: 35117211
[TBL] [Abstract][Full Text] [Related]
16. TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway.
Li L; Wang T; Li S; Chen Z; Wu J; Cao W; Wo Q; Qin X; Xu J
Front Oncol; 2020; 10():562823. PubMed ID: 33542896
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 70 positively regulates transforming growth factor-α-induced hepatocellular carcinoma cell migration via the AKT signaling pathway.
Kobayashi K; Matsushima-Nishiwaki R; Yamada N; Migita S; Hioki T; Mizutani D; Kozawa O
Heliyon; 2020 Sep; 6(9):e05002. PubMed ID: 33005803
[TBL] [Abstract][Full Text] [Related]
18. Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells.
Sun Y; Qin H; Zhang C; Xu J; Zhang T
BMC Complement Med Ther; 2024 Mar; 24(1):133. PubMed ID: 38539165
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of downregulated NISCH expression in skin cutaneous melanoma: Modulation of tumor cell invasion, migration, and EMT via PAK1 inhibition.
Hua HK; Zhu HM; Zhang ZG
Tissue Cell; 2024 May; 88():102399. PubMed ID: 38723330
[TBL] [Abstract][Full Text] [Related]
20. KLF4 Induces Mesenchymal-Epithelial Transition (MET) by Suppressing Multiple EMT-Inducing Transcription Factors.
Subbalakshmi AR; Sahoo S; McMullen I; Saxena AN; Venugopal SK; Somarelli JA; Jolly MK
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
